Skip to main content
Equibles

BNP PARIBAS ARBITRAGE, SA

Position in FATE — Fate Therapeutics Inc

CIK 1166588 NEW YORK, NY
Back to FATE Full portfolio

Position in FATE

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$733,411
+$702,553 QoQ
Shares Held
271,634
+956.3% QoQ
Ownership
0.227%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 156 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in FATE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BNP PARIBAS ARBITRAGE, SA holds $3,331,911,027 across 414 Biotechnology names. FATE ranks #136 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MRNA
Moderna, Inc.
 4,377,120 $306,529,713
2 REGN
Regeneron Pharmaceuticals, Inc.
 399,847 $249,320,598
3 ARGX
Argenx SE
 157,958 $146,548,693
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 262,258 $130,271,416
5 BNTX
BioNTech SE
 1,319,517 $122,781,056
6 RVMD
Revolution Medicines, Inc.
 552,710 $103,511,528
7 ORKA
Oruka Therapeutics, Inc.
 1,079,015 $102,689,857
8 BBIO
BridgeBio Pharma, Inc.
 1,155,442 $86,057,320

All Filings in FATE

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $733,411 271,634
2026-03-31 $30,858 25,715
2025-12-31 $28,709 29,295
2025-09-30 $34,468 27,356
2025-06-30 $321,901 287,412
2025-03-31 $270,366 342,236
2024-12-31 $474,723 287,711
2024-09-30 $609,518 174,148
2024-06-30 $40,580 12,372
2024-03-31 $344,701 46,962
2023-12-31 $87,441 23,380
2023-09-30 $510,019 240,575
2023-06-30 $2,426,662 509,803
2023-03-31 $4,146,675 727,487
2022-12-31 $2,790,530 276,564
2022-09-30 $5,987,458 267,178
2022-06-30 $2,645,215 106,748
2022-03-31 $1,687,464 43,525
2021-12-31 $4,105,120 70,161
2021-09-30 $1,900,670 32,068
2021-06-30 $1,095,810 12,626
2021-03-31 $1,124,453 13,638
2020-12-31 $1,070,518 11,773
2020-09-30 $671,136 16,791
2020-06-30 $3,920,569 114,269
2020-03-31 $654,128 29,452